Advertisement

Digestive Diseases and Sciences

, Volume 54, Issue 8, pp 1758–1763 | Cite as

Usefulness of FibroScan for Detection of Early Compensated Liver Cirrhosis in Chronic Hepatitis B

  • Do Young Kim
  • Seung Up Kim
  • Sang Hoon Ahn
  • Jun Yong Park
  • Jung Min Lee
  • Young Nyun Park
  • Ki Tae Yoon
  • Yong Han Paik
  • Kwan Sik Lee
  • Chae Yoon Chon
  • Kwang-Hyub HanEmail author
Original Article

Abstract

Background It is difficult to differentiate early compensated cirrhosis from chronic hepatitis solely by clinical features. The aim of this study was to assess the usefulness of liver stiffness measurement (LSM) for detection of early compensated liver cirrhosis in chronic hepatitis B (CHB). Methods Ninety-one consecutive CHB patients who underwent liver biopsy (LB) and LSM were recruited. All patients did not fulfill the clinical criteria for cirrhosis. The cutoff of LSM for cirrhosis was 10.3 kPa. Results All patients were divided into either group A (cirrhosis) or group B (CHB) according to LB result. The median LSM values of groups A and B were 11.8 and 7.6 kPa, respectively (P < 0.001). The sensitivity, specificity, positive predictive value, and negative predictive value of LSM in predicting cirrhosis were 0.59, 0.78, 0.68, and 0.72, respectively. The area under the receiver operating characteristics curve (AUROC) of LSM was 0.803, whereas the AUROCs of aspartate to alanine aminotransferase ratio (AAR) and aspartate aminotransferase to platelet ratio index (APRI) were 0.488 and 0.723, respectively. Conclusions LSM showed an acceptable diagnostic accuracy for detecting early compensated cirrhosis in CHB.

Keywords

Liver stiffness measurement Chronic hepatitis B Compensated liver cirrhosis 

Notes

Acknowledgments

This study was supported by the grant of the Good Health R & D Project from the Ministry of Health and Welfare, Republic of Korea (A050021), and in part by a grant from Brain Korea 21 Project for Medical Science.

References

  1. 1.
    Craxi A, Antonucci G, Camma C. Treatment options in HBV. J Hepatol. 2006;44:S77–S83. doi: 10.1016/j.jhep.2005.11.018.PubMedCrossRefGoogle Scholar
  2. 2.
    Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521–1531. doi: 10.1056/NEJMoa033364.PubMedCrossRefGoogle Scholar
  3. 3.
    Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495–500. doi: 10.1056/NEJM200102153440706.PubMedCrossRefGoogle Scholar
  4. 4.
    Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: Results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32:477–481. doi: 10.1053/jhep.2000.16602.PubMedCrossRefGoogle Scholar
  5. 5.
    Castéra L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350. doi: 10.1053/j.gastro.2004.11.018.PubMedCrossRefGoogle Scholar
  6. 6.
    Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54. doi: 10.1002/hep.20506.PubMedCrossRefGoogle Scholar
  7. 7.
    Marcellin P, de Ledinghen V, Dhumeaux D, et al. Non-invasive assessment of liver fibrosis in chronic hepatitis B using FibroScan. Hepatology. 2005;42:715A. abstract.Google Scholar
  8. 8.
    Imperiale TF, Said AT, Cummings OW, Born LJ. Need for validation of clinical decision aids: Use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C. Am J Gastroenterol. 2000;95:2328–2332. doi: 10.1111/j.1572-0241.2000.02322.x.PubMedCrossRefGoogle Scholar
  9. 9.
    Lackner C, Struber G, Bankuti C, Bauer B, Stauber RE. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005;41:1376–1382. doi: 10.1002/hep.20717.PubMedCrossRefGoogle Scholar
  10. 10.
    Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C: The METAVIR Cooperative Study Group. Hepatology. 1996;24:289–293. doi: 10.1002/hep.510240201.PubMedCrossRefGoogle Scholar
  11. 11.
    Fattovich G. Natural history of hepatitis B. In: EASL International Consensus Conference on Hepatitis B 2002, Gene`ve; 2002, 47–62.Google Scholar
  12. 12.
    Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997;112:463–472. doi: 10.1053/gast.1997.v112.pm9024300.PubMedCrossRefGoogle Scholar
  13. 13.
    Degos F, Christidis C, Ganne-Carrie N, et al. Hepatitis C virus related cirrhosis: Time to occurrence of hepatocellular carcinoma and death. Gut. 2000;47:131–136. doi: 10.1136/gut.47.1.131.PubMedCrossRefGoogle Scholar
  14. 14.
    Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut. 2004;53:744–749. doi: 10.1136/gut.2003.020263.PubMedCrossRefGoogle Scholar
  15. 15.
    Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut. 2005;55:403–408. doi: 10.1136/gut.2005.069153.PubMedCrossRefGoogle Scholar
  16. 16.
    Kim BK, Kim SA, Park YN, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int. 2007;27:969–976. doi: 10.1111/j.1478-3231.2007.01519.x.PubMedCrossRefGoogle Scholar
  17. 17.
    Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449–1457.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Do Young Kim
    • 1
    • 3
    • 4
  • Seung Up Kim
    • 1
    • 4
  • Sang Hoon Ahn
    • 1
    • 3
    • 4
  • Jun Yong Park
    • 1
    • 3
    • 4
  • Jung Min Lee
    • 1
    • 4
  • Young Nyun Park
    • 2
    • 4
  • Ki Tae Yoon
    • 1
    • 4
  • Yong Han Paik
    • 1
    • 3
    • 4
  • Kwan Sik Lee
    • 1
    • 3
    • 4
  • Chae Yoon Chon
    • 1
    • 3
    • 4
  • Kwang-Hyub Han
    • 1
    • 3
    • 4
    Email author
  1. 1.Department of Internal MedicineYonsei University College of MedicineSeoulSouth Korea
  2. 2.Department of PathologyYonsei University College of MedicineSeoulSouth Korea
  3. 3.Institute of GastroenterologyYonsei University College of MedicineSeoulSouth Korea
  4. 4.Liver Cirrhosis Clinical Research CenterSeoulSouth Korea

Personalised recommendations